NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate.
All recommendations are category 2A unless otherwise noted.
Clinical trials: NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.
Campbell PT, Patel AV, Newton CC et al.. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol 2013;31:876–885.
Dignam JJ, Polite BN, Yothers G et al.. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006;98:1647–1654.
Inoue-Choi M, Lazovich D, Prizment AE, Robien K. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention is associated with better health-related quality of life among elderly female cancer survivors. J Clin Oncol 2013;31:1758–1766.
- Search Google Scholar
- Export Citation
. Inoue-Choi M Lazovich D Prizment AE Robien K Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention is associated with better health-related quality of life among elderly female cancer survivors. J Clin Oncol 2013; 31: 1758– 1766.
Lee IM, Wolin KY, Freeman SE et al.. Physical activity and survival after cancer diagnosis in men. J Phys Act Health 2014;11:85–90.
Sinicrope FA, Foster NR, Yoon HH et al.. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol 2012;30:406–412.
Wyszynski A, Tanyos SA, Rees JR et al.. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer 2014;120:408–414.
Caan BJ, Emond JA, Su HI et al.. Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol 2012;30:1492–1497.
Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2011;4:486–501.
Chalfin HJ, Lee SB, Jeong BC et al.. Obesity and long-term survival after radical prostatectomy. J Urol doi: 10.1016/j.juro.2014.04.086.
Chan DS, Vieira AR, Aune D et al.. Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 2014;25:1901–1914.
Forsythe LP, Alfano CM, George SM et al.. Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 2013;137:617–630.
Ho T, Gerber L, Aronson WJ et al.. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. Eur Urol 2012;62:910–916.
Imayama I, Alfano CM, Neuhouser ML et al.. Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors. Breast Cancer Res Treat 2013;140:159–176.
Joshu CE, Mondul AM, Menke A et al.. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila) 2011;4:544–551.
Young A, Weltzien E, Kwan M et al.. Pre- to post-diagnosis weight change and associations with physical functional limitations in breast cancer survivors [published online ahead of print May 8, 2014]. J Cancer Surviv.
Pan H, Gray RG; on behalf of the Early Breast Cancer Trialists’ Collaborative Group. Effect of obesity in premenopausal ER+ early breast cancer: EBCTCG data on 80,000 patients in 70 trials [abstract]. J Clin Oncol 2014;32(Suppl):Abstract 503.
Caan BJ, Kwan ML, Shu XO et al.. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 2012;21:1260–1271.
Bertuccio P, Rosato V, Andreano A et al.. Dietary patterns and gastric cancer risk: a systematic review and meta-analysis. Ann Oncol 2013;24:1450–1458.
Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer 2014;1351884–1897.
Yusof AS, Isa ZM, Shah SA. Dietary patterns and risk of colorectal cancer: a systematic review of cohort studies (2000-2011). Asian Pac J Cancer Prev 2012;13:4713–4717.
Oyebode O, Gordon-Dseagu V, Walker A, Mindell JS. Fruit and vegetable consumption and all-cause, cancer and CVD mortality: analysis of Health Survey for England data. J Epidemiol Community Health 2014;68:856–862.
Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 2011;105(Suppl 1):S52–73.
Rock CL, Doyle C, Demark-Wahnefried W et al.. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012;62:242–274.
Meyerhardt JA, Niedzwiecki D, Hollis D et al.. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007;298:754–764.
Meyerhardt JA, Sato K, Niedzwiecki D et al.. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 2012;104:1702–1711.
McCullough ML, Gapstur SM, Shah R et al.. Association between red and processed meat intake and mortality among colorectal cancer survivors. J Clin Oncol 2013;31:2773–2782.
Kwan ML, Weltzien E, Kushi LH et al.. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol 2009;27:919–926.
Caan BJ, Natarajan L, Parker B et al.. Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 2011;20:854–858.
Guha N, Kwan ML, Quesenberry CP Jr et al.. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat 2009;118:395–405.
Arain MA, Abdul Qadeer A. Systematic review on “vitamin E and prevention of colorectal cancer”. Pak J Pharm Sci 2010;23:125–130.
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 2008:CD004183.
Chang YJ, Myung SK, Chung ST et al.. Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: a meta-analysis of randomized controlled trials. Dermatology 2011;223:36–44.
Cortes-Jofre M, Rueda JR, Corsini-Munoz G et al.. Drugs for preventing lung cancer in healthy people. Cochrane Database Syst Rev 2012;10:Cd002141.
Fife J, Raniga S, Hider PN, Frizelle FA. Folic acid supplementation and colorectal cancer risk: a meta-analysis. Colorectal Dis 2011;13:132–137.
Fortmann SP, Burda BU, Senger CA et al.. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2013;159:824–834.
Greenlee H, Hershman DL, Jacobson JS. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 2009;115:437–452.
Jeon YJ, Myung SK, Lee EH et al.. Effects of beta-carotene supplements on cancer prevention: meta-analysis of randomized controlled trials. Nutr Cancer 2011;63:1196–1207.
Mayne ST, Ferrucci LM, Cartmel B. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Annu Rev Nutr 2012;32:369–390.
Misotti AM, Gnagnarella P. Vitamin supplement consumption and breast cancer risk: a review. Ecancermedicalscience 2013;7:365.
Singal M, Banh HL, Allan GM. Daily multivitamins to reduce mortality, cardiovascular disease, and cancer. Can Fam Physician 2013;59:847.
Carroll C, Cooper K, Papaioannou D et al.. Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis. Clin Ther 2010;32:789–803.
Harris HR, Orsini N, Wolk A. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer 2014;50:1223–1231.
Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008;26:665–673.
Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014;4:CD000227.
Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 2012;11:CD000254.
Saller R, Brignoli R, Melzer J, Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed 2008;15:9–20.
Rambaldi A, Jacobs BP, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev 2007:CD003620.